Irritable Bowel Syndrome Trial, Recruiting NCT07584473 Sponsor: University of Palermo Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT07584473
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a family member (relative) of someone who has been diagnosed with Celiac Disease
  • You are over 18 years old
  • You currently experience symptoms similar to Irritable Bowel Syndrome or functional digestive problems (such as bloating, stomach pain, or discomfort), as well as symptoms that affect other parts of the body outside the digestive system

Who may not be able to join:

  • You have already removed wheat from your diet on your own and are not willing to reintroduce it for testing purposes
  • You have a problem with drug or alcohol use, including drinking more than roughly 2–3 standard drinks per day if you are a man, or more than 1–2 standard drinks per day if you are a woman
  • You have taken steroids or common anti-inflammatory painkillers (such as ibuprofen or aspirin) within the 2 weeks before a tissue sample is taken from your small intestine
  • You are currently pregnant or breastfeeding
  • You have been diagnosed with certain ongoing health conditions, including chronic inflammatory bowel diseases, a wheat allergy confirmed by the immune system, certain bowel or digestive conditions, neurological diseases, major mental health disorders, active infectious diseases, immune system deficiencies, or conditions that significantly limit your physical activity (confirm with trial site for the full list)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Antonio Carroccio, MD, University of Palermo

Phone: +393477279879

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Palermo
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
30 April 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Identification of patients with self-reported NCWS or IBS/FD not related to wheat intake among relatives of CD patients: Gastrointestinal Symptom Rating Scale (GSRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov